Revealed: Secret of HIV's natural born killers
Scientists on Sunday said they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus.
HIV & AIDS
Jun 10, 2012 |
4.6 / 5 (17) |
1
US delays decision on first drug to prevent HIV
(AP) — Drugmaker Gilead Sciences Inc. says federal health regulators have delayed a decision on whether to approve its drug Truvada as the first pill that prevents HIV infection.
Medications
Jun 09, 2012 |
1 / 5 (2) |
0
Researchers find that pre-existing mutations can lead to drug resistance in HIV virus
In a critical step that may lead to more effective HIV treatments, Harvard scientists have found that, in a small number of HIV patients, pre-existing mutations in the virus can cause it to develop resistance to the drugs ...
HIV & AIDS
Jun 07, 2012 |
5 / 5 (1) |
0
|
New data suggests HIV superinfection rate comparable to initial HIV infection
HIV superinfection, when a person with HIV could acquire a second, new strain of HIV, may occur as often as initial HIV infection in the general population in Uganda, a study suggests.
HIV & AIDS
Jun 07, 2012 |
5 / 5 (2) |
0
|
HIV drug may slow down metastatic breast cancer
The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study published in a recent issue ...
Cancer
Jun 06, 2012 |
not rated yet |
0
|
Antiretroviral treatment for preventing HIV infection: an evidence review for physicians
While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states a review of evidence published in CMAJ (Canad ...
HIV & AIDS
May 28, 2012 |
not rated yet |
0
Reactions to HIV drug have autoimmune cause, reports AIDS journal
Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according ...
HIV & AIDS
May 22, 2012 |
5 / 5 (1) |
0
FDA panel backs first rapid, take home HIV test
(AP) -- A panel of HIV specialists is recommending that U.S. regulators approve the first over-the-counter HIV test designed to quickly return a result in the privacy of a person's own home, a new option which could expand ...
HIV & AIDS
May 15, 2012 |
not rated yet |
0
Anti-HIV drug tenofovir is safe to take during pregnancy
Pre-birth exposure to the anti-HIV drug tenofovir does not adversely affect pregnancy outcomes and does not increase birth defects, growth abnormalities, or kidney problems in infants born to African women who are HIV positive, ...
HIV & AIDS
May 15, 2012 |
not rated yet |
0
HIV prevention measures must include behavioral strategies to work, says APA
A drug that has been shown to prevent HIV infection in a significant number of cases must be combined with behavioral approaches if the U.S. health care establishment is to succeed in reducing the spread of the virus, according ...
HIV & AIDS
May 14, 2012 |
not rated yet |
0
AIDS fight enters new phase with prevention pill
(AP) -- Condoms and other safe-sex practices have accomplished only so much. Now the 30-year battle against AIDS is on the verge of a radical new phase, with the government expected to endorse a once-a-day ...
HIV & AIDS
May 11, 2012 |
not rated yet |
1
FDA reviews first rapid, take-home test for HIV
The Food and Drug Administration is considering approval of the first over-the-counter HIV test that would allow consumers to quickly test themselves for the virus at home, without medical supervision.
HIV & AIDS
May 11, 2012 |
not rated yet |
0
Advocates: HIV prevention pill could save lives
(AP) -- A pill to prevent HIV infection is already being given to some healthy people, but without government approval, it remains out of reach and too costly for many who need it.
HIV & AIDS
May 11, 2012 |
5 / 5 (1) |
0
FDA panel backs first pill to block HIV infection
The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS.
HIV & AIDS
May 11, 2012 |
4 / 5 (1) |
0
US health advisors mull AIDS prevention pill (Update)
US health advisers on Thursday urged regulators to approve Truvada, made by Gilead Sciences, as the first preventive pill against HIV/AIDS instead of just a treatment for infected people.
HIV & AIDS
May 10, 2012 |
not rated yet |
0
